Anna Christine Hauser

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi A patient with sudden abdominal pain 10 years after successful renal transplantation
    Anna-Christine Hauser
    Division of Nephrology, Department of Medicine III, University of Vienna, , A-1090 Vienna, Austria
    Nephrol Dial Transplant 18:1021-5. 2003
  2. ncbi Fibrinolytic therapy with rt-PA in a patient with paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome
    A C Hauser
    Department of Internal Medicine III, Division of Nephrology and Dialysis, University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Ann Hematol 82:299-302. 2003
  3. ncbi Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease
    Anna Christine Hauser
    Department of Medicine III, Division of Nephrology and Dialysis, University of Vienna, Vienna, Austria
    Ophthalmologica 218:207-9. 2004
  4. ncbi The expanding clinical spectrum of Anderson-Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy
    A C Hauser
    Department of Medicine III, Division of Nephrology and Dialysis, University of Vienna, Vienna, Austria
    J Intern Med 255:629-36. 2004
  5. ncbi Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients
    Manuela Fodinger
    Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    J Am Soc Nephrol 14:1314-9. 2003
  6. ncbi Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients
    Manuela Fodinger
    Institute of Medical and Chemical Laboratory Diagnostics and Dialysis, Department of Medicine III, University of Vienna, Austria
    Kidney Int 64:1095-100. 2003
  7. ncbi The course of anticardiolipin antibody levels under immunoadsorption therapy
    Anna Christine Hauser
    Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria
    Am J Kidney Dis 46:446-54. 2005
  8. ncbi Results of a nationwide screening for Anderson-Fabry disease among dialysis patients
    Peter Kotanko
    , Teaching Hospital of the Karl Franzens University Graz, Department of Internal Medicine, Graz, Austria
    J Am Soc Nephrol 15:1323-9. 2004
  9. ncbi Therapy of Fabry disease
    Julia Kleinert
    Kidney Int 66:1288; author reply 1288-9. 2004

Collaborators

Detail Information

Publications9

  1. ncbi A patient with sudden abdominal pain 10 years after successful renal transplantation
    Anna-Christine Hauser
    Division of Nephrology, Department of Medicine III, University of Vienna, , A-1090 Vienna, Austria
    Nephrol Dial Transplant 18:1021-5. 2003
  2. ncbi Fibrinolytic therapy with rt-PA in a patient with paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome
    A C Hauser
    Department of Internal Medicine III, Division of Nephrology and Dialysis, University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Ann Hematol 82:299-302. 2003
    ..Our case shows that exclusive systemic application of rt-PA can result in full anatomic and clinical restoration...
  3. ncbi Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease
    Anna Christine Hauser
    Department of Medicine III, Division of Nephrology and Dialysis, University of Vienna, Vienna, Austria
    Ophthalmologica 218:207-9. 2004
    ..In order to identify unknown cases with Anderson-Fabry disease, we carried out a screening programme contacting Austrian ophthalmologists...
  4. ncbi The expanding clinical spectrum of Anderson-Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy
    A C Hauser
    Department of Medicine III, Division of Nephrology and Dialysis, University of Vienna, Vienna, Austria
    J Intern Med 255:629-36. 2004
    ..Early and accurate diagnosis is mandatory considering that this disorder is now, after introduction of the novel enzyme replacement therapy, a treatable disease...
  5. ncbi Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients
    Manuela Fodinger
    Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    J Am Soc Nephrol 14:1314-9. 2003
    ..In conclusion, GCP2 1561C>T, but not RFC1 80G>A, is a predictor of red blood cell folate level in chronic dialysis patients. Both polymorphisms have no major effect on tHcy plasma concentration in end-stage renal disease patients...
  6. ncbi Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients
    Manuela Fodinger
    Institute of Medical and Chemical Laboratory Diagnostics and Dialysis, Department of Medicine III, University of Vienna, Austria
    Kidney Int 64:1095-100. 2003
    ..The effect of TCN2 776C>G on vitamin B12 cellular availability in dialysis patients is unknown...
  7. ncbi The course of anticardiolipin antibody levels under immunoadsorption therapy
    Anna Christine Hauser
    Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria
    Am J Kidney Dis 46:446-54. 2005
    ..In an observational analysis, we studied anticardiolipin antibodies during immunoadsorption therapy...
  8. ncbi Results of a nationwide screening for Anderson-Fabry disease among dialysis patients
    Peter Kotanko
    , Teaching Hospital of the Karl Franzens University Graz, Department of Internal Medicine, Graz, Austria
    J Am Soc Nephrol 15:1323-9. 2004
    ..In dialysis patients, however, there is no evidence to support enzyme replacement therapy at present...
  9. ncbi Therapy of Fabry disease
    Julia Kleinert
    Kidney Int 66:1288; author reply 1288-9. 2004